© Copyright 2020 – CytoJournal – All rights reserved.
Published by Scientific Scholar on behalf of Cytopathology Foundation.
ISSN (Print): 0974-5963
ISSN (Online): 1742-6413
The CytoJournal is an open access peer-reviewed journal committed to publishing high-quality articles in the field of Diagnostic Cytopathology including Molecular aspects. The journal is owned by the Cytopathology Foundation and published by the Scientific Scholar.
Our open access audience includes Medical, Dental Veterinary, Basic Biological Sciences and All Allied Health Sciences.
CytoJournal has a highly rigorous peer-review process that makes sure that manuscripts are scientifically accurate, relevant, novel and important. Authors disclose all conflicts, affiliations and financial associations such that the published content is not biased.
The editorial board comprises of a panel of experts from various disciplines of Diagnostic pathology and other medical allied sciences to provide their expertise and guidance in maintaining the clarity of content and focus of the purpose for the journal with focus on diagnostic Cytopathology including molecular pathology.
It is a peer-reviewed international journal with a double-blind review process. Its frequency of publication is continuous, what that means is, it publishes the article once it’s accepted after peer review. Currently, we only have E-Journal. Print copies are available on demand.
An article published in the journal can be viewed without a fee by readers all over the world under open access charter. The author also gets to retain copyright to the article and the figures but they agree to share those with public globally. This allows authors to extend their exposure in the world of medical research and get worldwide recognition for their work with increased potential for higher impact including sharing of teaching points on various pitfalls and rare phenomenon.
The journal is registered with the following abstracting partners: Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing’s Electronic Databases, Ex Libris – Primo Central, Google Scholar, Hinari, Infotrieve, National Science Library, ProQuest, TdNet, Wanfang Data The journal is indexed with, or included in, the following: DOAJ, EMBASE/ Excerpta Medica, PubMed Central, Scimago Journal Ranking, SCOPUS, Science Citation Index Expanded Impact Factor® as reported in the 2018 Journal Citation Reports® (Clarivate Analytics, 2019): 1.042
The journal is registered with the following abstracting partners: Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing’s Electronic Databases, Ex Libris – Primo Central, Google Scholar, Hinari, Infotrieve, National Science Library, ProQuest, TdNet, Wanfang Data
The journal is indexed with, or included in, the following: DOAJ, EMBASE/ Excerpta Medica, PubMed Central, Scimago Journal Ranking, SCOPUS, Science Citation Index Expanded
Impact Factor® as reported in the 2018 Journal Citation Reports® (Clarivate Analytics, 2019): 1.042
The CytoJournal is committed to meeting and upholding the standards of ethical behavior at all stages of the publication process. We follow closely the industry associations, such as the Committee on Publication Ethics (COPE), International Committee of Medical Journal Editors (ICMJE) and World Association of Medical Editors (WAME), that set standards and provide guidelines for best practices in order to meet these requirements. For a summary of our specific policies regarding duplicate publication, conflicts of interest, patient consent, etc., please visit our Ethical Guidelines section.
We have plagiarism check available on our Editors and Reviewer’s panel in the manuscript management system. We encourage our editors and reviewers to use the plagiarism check. Any manuscript with plagiarism will be rejected immediately.
This is an open-access journal, and articles are distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Articles published online under the Ahead of Print model are considered published and can be cited and quoted using the DOI as the reference source. CytoJournal has a policy that changes will not be made after publication of an article without following accepted procedures for making corrections to the scientific record.
While advertisements maybe used, because they are crucial to this journal to be able to keep all content free for everyone, ethical considerations are in place to ensure the integrity of the journal and its content are not biased or influenced by the advertisement.
“Pop-up” and “banner” advertisement appears at a fixed location on the page and does not interfere with the manuscript in any form.
The Executive editor has full and final approval over the content of all advertisements.
Advertisers will never be shown any manuscripts or other content prior to publication.
Scientific Scholar, USA, established with the aim of publishing scientific journals. The mission of the company is “Share, Learn and Improve”.
Beginning in 2017, scientific journal publishing bought under the new umbrella of “Scientific Scholar”.
Imaging Science Today was founded in 2011 by a group of practicing doctors and industry specialists. It is a well-respected medical publisher that fully supports many of the popular open access models and all the aspects of the scientific journal publishing through its peer-review management system – Scientific Scholar and Open Access platform. The headquarter of Scientific Scholar is in Rochester, NY, USA and has a subsidiary arm in India.
Scientific Scholar currently publishes prestigious journals like the American Journal of Sonography and American Journal of Ophthalmic Clinical Trials includes CytoJournal and others is growing in its portfolio.